Evidence map›Paper›PMID 24464224›Full record

ArticleCell death and differentiation2014

DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferation.

D Pellacani, D Kestoras, A P Droop, F M Frame, P A Berry, M G Lawrence, M J Stower, M S Simms, V M Mann, A T Collins and 2 more

Open access · greenAbstract read
In one paragraph

Article in Cell death and differentiation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. DNA-Methyltransferase 1 Induces Dedifferentiation of Pancreatic Cancer Cells through Silencing of Krüppel-Like Factor 4 Expression.Clinical cancer research : an official journal of the American Association for Cancer Research · 2017
    Article
  7. Tumor necrosis factor-α decreases EC-SOD expression through DNA methylation.Journal of clinical biochemistry and nutrition · 2017
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

D PellacaniYCR Cancer Research Unit, Department of Biology, University of York, Wentworth Way, York, UK.
D KestorasYCR Cancer Research Unit, Department of Biology, University of York, Wentworth Way, York, UK.
A P DroopYCR Cancer Research Unit, Department of Biology, University of York, Wentworth Way, York, UK.
F M FrameYCR Cancer Research Unit, Department of Biology, University of York, Wentworth Way, York, UK.
P A BerryYCR Cancer Research Unit, Department of Biology, University of York, Wentworth Way, York, UK.
M G LawrenceProstate Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.
M J StowerYork District Hospital, Wigginton Road, City Centre, York, UK.
M S Simms1] Castle Hill Hospital, Castle Rd, Cottingham, East Yorkshire, UK [2] Hull York Medical School, University of Hull, Hull, UK.
V M Mann1] Castle Hill Hospital, Castle Rd, Cottingham, East Yorkshire, UK [2] Hull York Medical School, University of Hull, Hull, UK.
A T CollinsYCR Cancer Research Unit, Department of Biology, University of York, Wentworth Way, York, UK.
G P RisbridgerProstate Research Group, Department of Anatomy and Developmental Biology, Monash University, Clayton, Victoria, Australia.
N J MaitlandYCR Cancer Research Unit, Department of Biology, University of York, Wentworth Way, York, UK.
University of York · GBYorkshire Cancer Research · GBMonash University · AUHull York Medical School · GBUniversity of Hull · GBYork District Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prostate cancer (CaP) is mostly composed of luminal-like differentiated cells, but contains a small subpopulation of basal cells (including stem-like cells), which can proliferate and differentiate into luminal-like cells. In cancers, CpG island hypermethylation has been associated with gene downregulation, but the causal relationship between the two phenomena is still debated. Here we clarify the origin and function of CpG island hypermethylation in CaP, in the context of a cancer cell hierarchy and epithelial differentiation, by analysis of separated basal and luminal cells from cancers. For a set of genes (including GSTP1) that are hypermethylated in CaP, gene downregulation is the result of cell differentiation and is not cancer specific. Hypermethylation is however seen in more differentiated cancer cells and is promoted by hyperproliferation. These genes are maintained as actively expressed and methylation-free in undifferentiated CaP cells, and their hypermethylation is not essential for either tumour development or expansion. We present evidence for the causes and the dynamics of CpG island hypermethylation in CaP, showing that, for a specific set of genes, promoter methylation is downstream of gene downregulation and is not a driver of gene repression, while gene repression is a result of tissue-specific differentiation.

Indexed as

DNA MethylationAnimalsCell DifferentiationCell Growth ProcessesDown-RegulationEpithelial CellsHeterograftsHumansMaleMiceMice, Inbred BALB CPrognosisProstatic NeoplasmsTumor Cells, Cultured

Identifiers

PMID24464224
PMCPMC3978305
OpenAlexW2056423482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.